Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-naive Severe Aplastic Anemia”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04961710
What this trial is testing

Extension Study of Hetrombopag in Severe Aplastic Anemia

Who this might be right for
Treatment-naive Severe Aplastic Anemia
Jiangsu HengRui Medicine Co., Ltd. 157
Testing effectiveness (Phase 2)Study completedNCT03025698
What this trial is testing

A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia

Who this might be right for
Aplastic Anemia
Novartis Pharmaceuticals 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07001254
What this trial is testing

UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
Anjali Sharathkumar 15
Testing effectiveness (Phase 2)Study completedNCT04328727
What this trial is testing

Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia (SAA)
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT00260689
What this trial is testing

Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

Who this might be right for
ImmunosuppresionThrombocytopeniaPancytopenia+1 more
National Heart, Lung, and Blood Institute (NHLBI) 136
Large-scale testing (Phase 3)Not Yet RecruitingNCT07345000
What this trial is testing

Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia

Who this might be right for
Treatment-naïve Severe Aplastic Anemia
Qilu Pharmaceutical Co., Ltd. 210
Testing effectiveness (Phase 2)Study completedNCT01193283
What this trial is testing

Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia

Who this might be right for
Aplastic AnemiaNeutropeniaPancytopenia+1 more
National Heart, Lung, and Blood Institute (NHLBI) 22
Testing effectiveness (Phase 2)Study completedNCT02404025
What this trial is testing

Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects

Who this might be right for
Aplastic Anemia
Novartis Pharmaceuticals 10
Large-scale testing (Phase 3)Study completedNCT03825744
What this trial is testing

Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
Jiangsu HengRui Medicine Co., Ltd. 240
Testing effectiveness (Phase 2)Active Not RecruitingNCT01623167
What this trial is testing

Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 207
Testing effectiveness (Phase 2)Looking for participantsNCT04304820
What this trial is testing

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Who this might be right for
Severe Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 80